AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Update

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 93,400 shares, a decline of 31.0% from the October 31st total of 135,400 shares. Based on an average daily trading volume, of 1,029,000 shares, the short-interest ratio is presently 0.1 days.

AXIM Biotechnologies Price Performance

AXIM Biotechnologies stock traded up $0.00 during mid-day trading on Friday, reaching $0.00. 515,677 shares of the company traded hands, compared to its average volume of 486,912. AXIM Biotechnologies has a 52-week low of $0.00 and a 52-week high of $0.02.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.